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ABSTRACT 
Background: The epicardial adipose tissue is located between the myocardium 
and the visceral pericardium, lying directly above the myocardium without any 
fascia. Epicardial adipose tissue presents itself with histological features typical of 
the brown adipose tissue. It plays a cardioprotective role through 
thermoregulation, energy homeostasis and anti-inflammatory regulation. 
However, in pathological conditions, epicardial adipose tissue may have a pro-
inflammatory effect. Less is known about the role played by epicardial adipose 
tissue in patients with a history of atrial fibrillation. Some studies suggest an 
association between increased epicardial adipose tissue (volume and thickness) 
and atrial fibrillation. Nonetheless, there is little data about histological 
characterisation of epicardial adipose tissue in patients with a history of atrial 
fibrillation. 
Aim of the study: To evaluate the quantitative (using echocardiography) and 
qualitative characteristics (intra-operatory biopsy for histological characterisation) 
of epicardial adipose tissue in relation to atrial fibrillation burden after coronary 
artery bypass graft. 
Patients and methods: Prospective single-centre study approved by the ethics 
committee of Verona and Rovigo in July 2018. Patients undergoing coronary 
artery bypass graft with preserved left ventricular ejection fraction were included, 
after giving informed consent. Patients with atrial fibrillation and 
immunosuppressive therapy history were excluded. All enrolled patients 
underwent a medical evaluation to collect clinical history, a transthoracic 
echocardiography to measure epicardial adipose tissue thickness and collection of 
a bioptic sample containing right appendage and epicardial adipose tissue during 
coronary artery bypass graft. After surgery post-surgical clinical course and 
telemetry were collected. Lastly, histological characterisation (PLIN1 and 
fibrosis) of the bioptic samples was performed. 
Results: 56 patients undergoing coronary artery bypass graft were enrolled 
between 10th September 2018 and 3rd September 2019 in Cardiology and Cardiac 
Surgery departments. The mean hospitalisation was 11,9 ± 6,9 days and the 
postsurgical hospitalisation was 7,9 ± 3,7 days. 44 (78,6%) patients were male and 
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the median age was 68,45 ± 9,2 years. All patients were continuously monitored 
with telemetry from the day of cardiac surgery until discharge. No major 
complications occurred, only one death unrelated to the surgery. Out of the total 
number of patients, 22 (39%) had at least one episode of atrial fibrillation. In the 
population that developed atrial fibrillation there was a bigger atrial volume, a 
higher degree of diastolic disfunction (E/A rate), a thicker layer of epicardial 
adipose tissue and an older median age in comparison to the group that did not 
develop it. Epicardial adipose tissue measured using echocardiogram with a cut 
off of 4 mm was a predictor of atrial fibrillation with an OR of 1,49 [1,09-2,04], 
73% of sensibility and 89% of specificity. Furthermore, from the histological 
analyses of biopsies, the patients with atrial fibrillation had a significantly higher 
percentage of fibrosis, while adipose infiltration was not significantly higher. 
Through univariate analysis, atrial volume (OR 1,05 CI 1,01-1,09, p 0,022), E/A 
rate (OR 0,04 CI 0,02-0,72 p 0,29), the percentage of fibrosis (OR 1,12 CI 1,00-
1,25 p 0,045) and age (OR 1,17 CI 1,07-1,28 p 0,001) were predictors of atrial 
fibrillation as well as the thickness of the epicardial adipose tissue. Through 
multivariate analysis atrial volume (p 0,027), fibrosis (p 0,003) and age (p 0,039) 
were independent predictors of atrial fibrillation. 
Conclusion: Post cardiac surgical atrial fibrillation is frequent. Epicardial adipose 
tissue measured by echocardiogram, atrial volume, fibrosis and age are predictors 
of post cardiac surgical atrial fibrillation. 
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INTRODUCTION 
 
Atrial Fibrillation 
Atrial fibrillation is the most frequent sustained cardiac arrhythmia in humans 
with a prevalence of around 3% in the general adult population over 20 years of 
age. The incidence of atrial fibrillation increases progressively with age, from 
0.5% in the 40-50 age group, to 5-15% beyond 80 years old, and affects men more 
frequently than women.1 The prevalence of atrial fibrillation has increased 
steadily in recent decades, both as a result of the ageing of the general population 
and the improvement of diagnostic tools, and is expected to double over the next 
50 years in Europe.2 Atrial fibrillation is a potentially disabling arrhythmia. It 
leads to an increase in chance of death, thromboembolic events, heart failure and 
hospitalisations, negatively affects quality of life and ability to exercise, and lastly 
can cause left ventricular dysfunction. The most known and feared complication 
of atrial fibrillation is cardioembolic stroke, where risk increases by 5% compared 
to the general population and represents 20% of all causes of stroke. 
Cardioembolic stroke secondary to atrial fibrillation often also has a higher degree 
of clinical severity when compared to strokes of another origin, resulting in long-
term disability or death.3 
The cardioembolic risk in atrial fibrillation is conventionally defined by a risk 
score, that takes into account some important clinical features (CHA2DS2VASC - 
congestive heart failure, arterial hypertension, age >65-75 years, diabetes mellitus, 
previous cardioembolic event, vascular disease and female gender) and does not 
seem to be significantly influenced by the pattern and clinical features of 
arrhythmia manifestation.4 The general treatment of atrial fibrillation should 
primarily aim at preventing thromboembolic events through appropriate 
anticoagulant therapy, then at alleviating symptoms, controlling heart rate and 
restoring sinus rhythm whenever possible. It is important to treat coexisting 
cardiovascular diseases that could play a pathogenic role in the origin and 
maintenance of the arrhythmia and increase the risk of complications related to 
atrial fibrillation. 
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Regarding the strategy of maintaining sinus rhythm, in addition to the traditional 
pharmacological approach which uses antiarrhythmic drugs, in recent years 
extensive development has found non-pharmacological strategies. One strategy in 
particular includes ablative techniques aimed at treating the substrate of atrial 
fibrillation. Atrial fibrillation ablation usually performed percutaneously and only 
rarely surgically, can use various sources of energy, the most common being 
radiofrequency and cryoenergy, and lastly laser source. These methods, when 
properly followed, have proven to be very effective in the treatment of the 
arrhythmia, in some cases resulting in a complete cure from recurrences. 
From a pathophysiological point of view, the activation and perpetuation of a 
tachyarrhythmia require both a trigger and a substrate for its maintenance. 
Triggers play a key role in initiating the arrhythmia, in most cases the main 
location being the pulmonary veins. They can also be located in the posterior wall 
and, less frequently, in other sites in the left atrium. The mechanisms of 
arrhythmia maintenance require multiple re-entry circuits. This kind of 
electrophysiological mechanism requires the presence of a substrate, generally 
characterised by structural alterations of the atrial musculature. In the mechanism 
of multiple re-entry, the atrial fibrillation is perpetuated by the constant presence 
of a series of independent circuits. These propagate in an almost chaotic way 
inside the atrial wall with wave fronts that constantly interfere with each other, at 
times fragmenting and giving rise to further activation waves, at times blocking, 
colliding or merging and thus becoming numerically inferior. The predominance 
of substrate, trigger or focal activity accounts for different clinical types of atrial 
fibrillation. In focal atrial fibrillation, or lone atrial fibrillation, triggers and focal 
activity are the key factors in the origin of the arrhythmia, while in persistent or 
permanent atrial fibrillation the role of the substrate prevails over that of the 
triggers. 
Atrial fibrillation from an electrocardiographic point of view is characterised by 
irregular RR intervals where a repetitive pattern is not recognisable, absence of P 
waves and atrial cycle duration <200 ms (>300 bt/min). Atrial fibrillation is 
diagnosed by recording a standard 12-lead electrocardiogram (ECG) or an ECG 
trace of at least 30 seconds.3 Continuous monitoring of this arrhythmia for a 
Università degli Studi di Verona  
Area Ricerca – U.O. Dottorati di Ricerca Nazionali ed Internazionali 
tel. 045.802.8608 - fax 045.802.8411 - Via Giardino Giusti n. 2 - 37129 Verona  
8 
limited period of time can be done by systems such as 24-hour Holter ECG, 
hospital telemetry, or, in cases where more prolonged monitoring is needed, with 
external loop recorders or implantable loop recorders. 
Based on the presentation, duration, and spontaneous termination of the episodes, 
five types of atrial fibrillation are traditionally distinguished. Paroxysmal in cases 
where the duration is less than 7 days, by spontaneous sinus rhythm cardioversion 
or induced cardioversion. It’s defined persistent in forms lasting more than 7 days 
and permanent in those forms for which no rhythm control interventions are 
consensually undertaken by the doctor and by the patient.3 Lastly, silent 
(asymptomatic) atrial fibrillation may have as its first manifestation a 
complication related to the arrhythmia itself (ischemic stroke or 
tachycardiomyopathy) or may be diagnosed following a chance ECG. It may 
present itself as any of the temporal forms of atrial fibrillation described above. 
Continuous monitoring systems can be useful in defining the atrial fibrillation 
burden, which is defined as the total time the patient spends in arrhythmia 
regardless of the number of episodes or mode of presentation. 
 
Atrial fibrillation and cardiac surgery  
Postoperative atrial fibrillation is a common occurrence that can affect 20 to 50% 
of patients undergoing cardiac surgery (about 30% after coronary artery by-pass 
graft, 40% after valvular surgery and 50% after combined by-pass and valvular 
surgery).5,6 These numbers are expected to increase in the coming years as the 
average age of patients undergoing cardiac surgery increases, considering that the 
incidence of this arrhythmia is strongly correlated with increasing age. The peak 
of the post-operative arrhythmic incidence is between the 2nd and 4th day after 
surgery, particularly on the second day.6 Although this arrhythmia is generally 
well tolerated and considered a temporary problem related to the surgery, it is 
associated with worse clinical outcomes in the short and long term, leading to an 
increased risk of death, hospitalisation and complications such as stroke, heart 
failure and infections.7,8 In particular, the risk of postoperative and perioperative 
stroke is about 3 times higher in patients with episodes of atrial fibrillation after 
cardiac surgery. From a financial standpoint, the onset of atrial fibrillation in the 
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postoperative cardiac surgery period can prolong hospitalisation times, impacting 
patient management costs.9 
From a pathophysiological point of view the mechanisms of appearance and 
maintenance of postoperative atrial fibrillation are not yet fully known. It is likely 
that this arrhythmia requires the presence of an electrophysiological substrate that 
allows the propagation of multiple re-entry waves resulting from a dispersion of 
atrial refractoriness. The latter requires a structural atrial substrate, which could be 
a consequence of the association of several factors predisposing the arrhythmia 
itself, such as advanced age, arterial hypertension, diabetes mellitus, obesity, atrial 
enlargement, and factors related to the cardiac surgery itself. Some perioperative 
causative mechanisms have been proposed that include pericardial inflammation, 
excessive production of catecholamines, autonomic imbalance during the 
postoperative period, and interstitial mobilization of fluid with resultant changes 
in volume, pressure, and neurohumoral environment. These factors might alter the 
atrial refractoriness and slow atrial conduction.6 Finally, inflammation and 
oxidative stress could play an important role in this scenario, as well as pericardial 
fat. Atrial fibrosis, which is the result of an inflammatory process and of 
metabolic disorder, is considered a key element of atrial remodelling. Numerous 
clinical and experimental studies in recent years have suggested that pericardial 
fat, such as atrial fibrosis, is strongly associated with the incidence, maintenance 
and recurrence of atrial fibrillation. 
A greater understanding of the causes of this arrhythmia could help in the 
prevention and treatment after the onset of postoperative atrial fibrillation. 
 
Cardiac adipose tissue 
The heart is surrounded by a variable amount of perivisceral adipose tissue, 
visible on its surface. This manifests on the atrioventricular grooves, the posterior 
part of the atria, on the appendages and along the larger coronary arteries. Under 
physiological conditions it represents about 20% of the heart mass. It consists of a 
paracardial component, placed outside of the visceral pericardium, and an 
epicardial component placed between the visceral pericardium and epicardium, 
and combined they make pericardial fat (Figure 1). The epicardial and paracardial 
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adipose tissue have different embryonic origins and different biological properties. 
The epicardium consists of a population of mesothelial cells originating from the 
transverse septum area which migrate to the surface of the heart. The epicardial 
fat originates from the splanchnopleuric mesoderm similarly to mesenteric and 
omental fat, while the paracardial fat originates from the primitive thoracic 
mesenchyme. For this reason, the vascularisation is also different between the two 
types of fat.  Coronary circulation supplies epicardial fat, while non-coronary 
circulation supplies paracardial fat.10 A further anatomical distinction in regard to 
epicardial fat can be made between myocardial and pericoronary components. The 
latter directly surrounds the coronaries on the adventitia, while the myocardial 
component is in direct contact with the myocardial muscle itself. Whether there 
are functional differences between these two components is unclear. 
 
 
 
Figure 1: The structure of pericardial fat consisting of a paracardial component 
located outside of the visceral pericardium and an epicardial component located 
between the visceral pericardium and epicardium. 
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The properties of epicardial adipose tissue  
Epicardial adipose tissue is in direct contact with the adjacent myocardium 
without the interposition of any barrier. Both these structures share the same 
microcirculation (Figure 2). The lack of an anatomic barrier between adipose 
tissue and myocardium allows paracrine activity between the two tissues, also 
favoured by a dense network of vasa-vasorum. Epicardial fat is a biologically 
active organ and expresses uncoupling Protein-1 (UCP-1), a protein of the inner 
mitochondrial membrane, which typically characterises brown adipose tissue.11 It 
has a high capacity for free fatty acid release and low glucose consumption 
(higher capacity than other adipose tissues). Its biochemical properties suggest a 
role in providing the myocardium with energy and protection from hypothermia. 
Lastly, epicardial adipose tissue produces numerous cytokines and adipokines that 
affect the surrounding tissue. These same properties under pathological conditions 
may promote paracrine and vasocrine secretion of pro-inflammatory cytokines. 
What balances this equilibrium is still unclear. Both the quantity and the 
biological activities of this tissue vary from subject to subject. Local 
vascularisation, weight loss and targeted drug therapy could promote the 
physiological properties of epicardial fat. In subjects with coronary heart disease, 
less anti-atherogenic adipokines and less anti-inflammatory cytokines are secreted 
in favour of more tumor necrosis factor (TNF) alpha, Interleukin-6 and 
chemokines such as monocyte chemoattractant protein-1 (MCP-1).12,13,14 In 
addition, epicardial adipose tissue may contribute to myocardial insulin resistance 
by secreting TNF-alpha, which inhibits the insulin receptor and increases the 
release of non-esterified fatty acids. 
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Figure 2: Epicardial adipose tissue in direct contact with the adjacent 
myocardium without the interposition of any anatomical barrier. The lack of 
barrier between epicardial adipose tissue and myocardium allows paracrine 
activity between the two tissues. 
 
Intracellular adipose infiltration  
Epicardial adipose tissue could play a pathological role not only through paracrine 
activity, but also through direct local infiltration between myocardial cells.  In turn 
this could promote fibrosis of the extracellular matrix, and within them the so-
called myocardial steatosis. It is well known that excess fatty acids are 
sequestered as triglycerides and stored in adipocytes or as lipid droplets. This 
phenomenon also occurs in tissues other than adipose, such as the liver, the 
pancreas, skeletal muscle and the heart. Some scientific data suggest that cardiac 
steatosis may have harmful effects on cardiomyocyte function regardless of the 
effects that may result from increased generalised adiposity or high blood lipid 
levels.15 
 
Adipose tissue and atrial fibrillation 
In recent years the association between epicardial and paracardial adipose tissue 
and atrial fibrillation has been studied, highlighting a possible role of these tissues 
in the onset and maintenance of arrhythmia, and in the recurrences after 
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percutaneous ablation with both radiofrequency16 and cryoablation.17 This 
correlation would depend both on paracrine properties, similar to those described 
above for coronary artery disease, and on direct adipose infiltration between the 
myocardial fibres. The latter would be able to promote atrial remodelling typical 
of atrial fibrillation and change myocardial electrical properties causing a 
slowdown of atrial conduction and thus favouring mechanisms of re-entry. 
Most studies have used non-invasive imaging methods to study cardiac fat, 
without making a clear distinction between epicardial and paracardial tissue. A 
recent animal study compared a group of 10 sheep on a hypercaloric diet that 
made them obese, to a group of 10 sheep on a normocaloric diet.18 The analysis of 
the atrial substrate for atrial fibrillation was carried out in both groups. The obese 
sheep group showed greater atrial vulnerability to the onset of atrial fibrillation 
and a greater burden. This group compared to the normal-weight sheep group had 
a higher fat infiltration histologically at the atrial myocardial level, and a higher 
percentage of atrial fibrosis and expression of tumor growth factor (TGF) beta. 
 
Aims of the study 
There has been little research of intra-operative epicardial fat in the context of 
atrial fibrillation. The objective of this study is to investigate the correlation 
between epicardial fat and atrial fibrillation in a postoperative context of patients 
undergoing cardiac surgery both through imaging and histological analysis of fat 
taken during cardiac surgery. 
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MATERIALS AND METHODS  
 
Study design  
An experimental monocentric study with no use of drugs or devices was 
conducted, aimed at assessing the role of epicardial fat in the pathogenesis of 
atrial fibrillation by echocardiographic and histological analysis of pericardial fat. 
Figure 3 summarises the design of the study. 
 
 
 
 
Figure 3: Study design. 
 
 
Definition of atrial fibrillation burden 
Atrial fibrillation burden is defined as the amount of time a person spends in atrial 
fibrillation, quantifiable by the number of episodes of arrhythmia and the duration 
of each episode.  
 
Study objectives 
Primary objective: To study the relationship between pericardial fat in its 
epicardial and paracardial components (measured by a preoperative 
echocardiogram) and atrial fibrillation burden in the immediate postoperative 
period.  
Secondary objectives: Histological typing of fibrosis and of lipid infiltration of 
epicardial fat in relation to atrial fibrillation burden in the immediate 
postoperative period. Study of the correlation between epicardial and paracardial 
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fat and preoperative echocardiographic parameters predictive of atrial fibrillation, 
such as atrial strain, atrial size and diastolic function. 
 
Study end points 
Primary end point: Burden of atrial fibrillation in the immediate postoperative 
period in relation to epicardial fat measured in mm, by a preoperative 
echocardiogram with a long axis parasternal view.  
Secondary end points: Burden of atrial fibrillation in the immediate postoperative 
period in correlation with the percentage of extracellular lipid markers known as 
Perilipin 1 (PLIN1) in the biopsy collection, percentage of fibrosis in the 
perimyocardial biopsy collection, atrial strain, atrial size in ml and degree of 
diastolic dysfunction. 
 
Study population  
The study was approved by the CESC Ethics Committee of the Provinces of Ve-
rona and Rovigo, N. Prot. 1744 CESC, on 26th July 2018. The enrolments were 
carried out for 12 months involving patients belonging to the ‘Complex Operating 
Unit of Cardiovascular Diseases and Cardiac Surgery of the Integrated University 
Hospital of Verona’ (AOUI Verona), who met the criteria of inclusion and exclu-
sion of the study.  
 
Inclusion criteria - Candidates for cardiac surgery of coronary artery bypass surgery with is-
chemic heart disease and preserved ejection fraction;  - Sex: male and female;  - Age: adult patients able to express direct informed consent over 18 years 
old;  - Patients without a history of atrial fibrillation;  - Adhesion to the informed consent. 
 
Exclusion criteria  - Pregnancy status;  
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- Patients unable to provide informed consent;  - Candidates for valvular surgery;  - Myocardial contractility deficit quantifiable by echocardiogram ejection 
fraction (less than 50%);  - Patients with known autoimmune or auto-inflammatory diseases;  - Patients with chronic atrial fibrillation;  - Patients with atrial fibrillation at enrolment. 
 
Enrolment and preoperative evaluation 
During the hospitalisation for cardiac surgery, candidates for coronary artery 
bypass surgery were evaluated. After verification of the inclusion and exclusion 
criteria, eligible patients were enrolled. Each patient was booked in after signing 
informed consent. Demographic and clinical-anamnestic information such as age, 
weight and height, cardiovascular risk factors, history of cardiovascular diseases, 
coronarographic data and any ongoing medical treatment before surgery was 
collected from each patient. In addition, clinical data were collected such as basal 
haematochemical values, in particular blood counts, electrolytes, liver function, 
kidney function, thyroid function, glycolipid function, glycated haemoglobin, 
uricemia, C reactive protein (CRP), procalcitonin (PCT) and fibrinogen. 
An electrocardiogram was also performed for each patient to evaluate sinus 
rhythm. Furthermore, a complete echocardiogram was performed to measure epi 
and paracardic fat, particularly in long axis parasternal view at the aortic root, and 
in short axis. It included moreover measurement of atrial and ventricular strain, 
systolic function, diastolic function and atrial size. The choice of an 
ultrasonography as the imaging method for the evaluation of pericardial fat was 
dictated by the fact that the echocardiogram is an appropriate tool in predicting the 
correlation between the amount of pericardial fat measured and the burden of 
atrial fibrillation in different populations studied. In addition, it is a routine 
preoperative exam for the enrolled patients, while the use of other methods such 
as a computed tomography (CT) sca or magnetic resonance would have increased 
costs and length of hospital stay and might have required the administration of 
contrast medium in certain cases. 
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Biopsy collection and immunohistochemical analysis 
Each biopsy was performed by the cardiac surgeon during surgery. The collection 
included waste tissue from the surgery, in particular a specimen of the right atrial 
appendage containing epicardial fat. The biopsy samples taken in the operating 
room were collected in a test tube containing 10% neutral buffered formalin and 
then stored in a 4°C temperature refrigerator until the analysis. The latter was car-
ried out by expert personnel from the ‘University Laboratory of Medical Re-
search’ (LURM) at ‘Policlinico G. Rossi’ in Verona. 
At the LURM centre, analyses were performed to determine the degree of adipose 
infiltration and fibrosis on the right appendage specimen. Fibrosis in myocardium 
samples under examination was evaluated by Masson trichromic staining with nu-
clear staining (with Weigert's ferric hematoxylin) and connective staining (with 
aniline blue). The full biopsy preparations were analysed using the PluginCol-
ourDeconvolution with 100x magnification images, which divided the fibrosis 
zones in blue and the muscle zones in red in two different images. Fibrosis was 
calculated as the percentage of blue fibres among cardiomyocytes in relation to 
the total area determined by the sum of blue fibres and muscle in red (% = total 
blue area *100/; total blue area+red). 
Specimens were obtained from atrial biopsies to determine lipid infiltration of the 
myocardium as adipocytes present between the cardiomyocytes using the PLIN 1 
marker. The specimens obtained were observed using an Olympus BX51 optical 
microscope equipped with a KY-F58 CCD (JVC) camera. The images were cap-
tured using Image-ProPlus (software version 7. 0). Image analysis and quantifica-
tion was performed using ImageJ (software version 1. 49s). The biopsy sections 
obtained were incubated with rabbit PLIN1 primary anti-human antibodies specif-
ic for marking adipocytes. The degree of adipocyte infiltration was expressed as 
the number of adipocytes marked with PLIN1 per square millimetre. 
 
Postoperative assessments  
The burden of atrial fibrillation in patients who developed this in the immediate 
postoperative period was assessed by telemetry analysis both in intensive care unit 
and in the cardiac surgery ward from the day of surgery until discharge. Both the 
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total duration of telemetric monitoring of individual postoperative patients and the 
number of episodes of atrial fibrillation with the relative duration of each episode 
were quantified. ECG traces were also collected. 
Data were collected on postoperative clinical progress, in particular the 
requirement of cardiac inotropic drugs, postoperative anaemia requiring 
hemotransfusion, increase in inflammatory markers, need for chest drainage, 
duration of hospitalisation, other possible complications or death. Lastly, the pre-
discharge basal blood chemistry values and the therapy with which each patient 
was discharged were noted from the medical records. 
 
Statistical analysis  
The estimate of the population to be recruited to achieve significance was 
calculated using the statistical program PASS 14. 0. 8 and the Logistic Regression 
module. The data collected was summarised using elements of descriptive 
statistics. The continuous variables are reported as average ± standard deviation 
(SD), the categorical variables are expressed as a percentage of the total. The 
comparison between groups was made by averaging the Student t-test for 
unpaired data. For paired data the comparison between groups was done by Chi 
Square analysis. Logistic regression was applied to analyse the predictors of an 
atrial fibrillation event. For the analysis of independent predictors, the MANOVA 
analysis was used. ROC analysis was applied to test the predictive value and the 
sensitivity and specificity of epicardial fat at a given cut-off in predicting events. 
This predictive power was finally tested with a square Chi test. The level of 
statistical significance was set at 5%. The statistical analyses were conducted 
using the IBM SPSS Statistics program, 2 Version 20. 0. (Armonk, NY, USA: 
IBM Corp.). 
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RESULTS  
 
Population studied  
56 patients were enrolled between 10th September 2018 and 3rd September 2019. 
These patients belonged to the ‘Complex Operating Unit of Cardiovascular Dis-
eases and Cardiac Surgery of the AOUI Verona’ and were candidates for coronary 
artery bypass surgery. Enrolled patients entered an elective hospitalisation regime 
for cardiac surgery or an emergency regimen for recent onset angina with an indi-
cation for cardiac surgery treatment. The average stay was 11.9 ± 6.9 days, while 
the postoperative course from the day of surgery was 7.9 ± 3.7 days. 
Out of 56 patients, in addition to the coronary artery bypass surgery, one case un-
derwent aortic valve replacement for intraoperative valve mass finding and anoth-
er underwent interatrial defect closure. Out of the enrolled patients 44 (78.6%) 
were male, with an average age of 68.45 ± 9.2 years. All patients were continu-
ously monitored with telemetry from the day of cardiac surgery both in the inten-
sive care unit and in the cardiac surgery ward until discharge. With regard to post-
operative complications, most minor complications were resolved with minor in-
terventions as summarised in Table I. One patient underwent coronarography for 
venous by-pass closure with good results. Another patient died from relapsing and 
severe gastrointestinal anaemia, unrelated to the recent cardiac surgery. 
 
Hospital Stay and Post-surgical Course N=56  
Variables Value 
Length of average Hospital Stay (days ± SD) 11.9 ± 6.9 
Length of average Post-surgical Course (days ± SD) 7.9 ± 3.7 
Elective Cardiac Surgery (n/N %) 33 (58.9) 
Transfusion-needing anemization (n/N %) 30 (53.6) 
Thoracentesis-needing Pleural Effusion (n/N %) 10 (17.8) 
Increase of inflammation markers (n/N %) 9 (16.1) 
Indication of postoperative CGF (n/N %) 1 (1.8) 
Death (n/N %) 1 (1.8) 
Table I: Hospital Stay and Post-surgical Course-related Variables. CGF: coro-
narography 
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Postoperative atrial fibrillation 
Of the 56 patients enrolled, 22 (39.3%) had at least one episode of postoperative 
atrial fibrillation. Details about the population who had postoperative atrial fibril-
lation are summarised in Table II. 
 
AF Patients N=22 
Variables Valore 
Average Duration of post-surgical telemetrics (hours ± SD) 190.3 ± 89.8 
Recorded AF episodes (n ± SD) 1.5 ± 0.8 
AF burden (hours ± SD) 43.8 ± 39.5 
Administration of amiodarone for AF treatment n/N (%) 22/22 (100) 
Electrical Cardioversion n/N (%) 1/22 (4.5) 
Discharge in sinus rhythm n/N (%) 21/22 (95.5) 
Table II: Data concerning patients affected by atrial fibrillation after surgery. 
AF: atrial fibrillation 
 
The comparison of the general characteristics of the population that had atrial fi-
brillation with the population that did not have it is shown in Table III. 
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AF vs. non-AF patients 
Clinical variables Non-AF 
(N=34) 
AF  
(N=22) 
P value 
Age (years ± SD) 64.5 ± 8.5 74.1 ± 6.7 <0.001** 
Male n/N (%) 28 (84.8) 15 (68.2) 0.188 
BMI (n ± SD) 27.2 ± 4.3 27.2 ± 4.0 0.941 
Hypertension n/N (%) 24 (72.7) 16 (72.7) 1.000 
Dyslipidemia n/N (%) 19 (57.6) 10 (45.5) 0.420 
Pre-admission statin 24 (70.6) 17 (77.3) 0.581 
Pre-admission beta blockers 19 (55.9) 17 (77.3) 0.103 
Chronic Renal Failure n/N (%) 4 (12.1) 4 (18.2) 0.700 
Tobacco Smoking n/N (%) 4 (12.1) 4 (18.2) 0.700 
Diabetes n/N (%) 10 (30.3) 7 (31.8) 1.000 
Peripheral vascular disease n/N (%) 32 (97.0) 21 (95.5) 0.380 
ACS at admission n/N (%) 15 (44.1) 8 (36.4) 0.565 
EF (n ± SD) 56.3 ± 4.5 55.8 ± 5.8 0.690 
Atrial Volume (ml ± SD) 51.9 ± 13.4 64.2 ± 19.5 0.015** 
TAPSE (mm ± SD) 24.2 ± 3.9 22.8 ± 3.9 0.268 
E/A rate (n ± SD) 0.93 ± 0.24 0.77 ± 0.22 0.021** 
E/E’ rate (n ± SD) 8.8 ± 3.6 11.9 ± 5.6 0.070 
Epicardial fat thickness (mm ± SD) 2.7 ± 1.9 4.1 ± 1.7 0.006** 
Paracardiac fat thickness (mm ± SD) 4.9 ± 3.0 5.4 ± 2.1 0.571 
Pericardial fat thickness (mm ± SD) 7.6 ± 3.5 9.5 ± 3.0 0,064 
MAPSE (mm ± SD) 10.3 ± 2.8 11.7 ± 2.3 0.240 
Surgery duration (min ± SD) 286.6 ± 44.7 291.0 ± 65.1 0.781 
Aortic balloon pump n/N (%) 5 (15.2) 1 (4.5) 0.384 
Treated vessels (n ± SD) 2.6 ± 0.9 2.2 ± 0.7 0.102 
Inotropics use n/N (%) 15 (44.1) 15 (68.2) 0.097 
Transfusion-needing anemization n/N (%) 17 (51.5) 12 (54.5) 1.000 
Post-surgical course duration (days ± SD) 7.9 ± 4.0 8.1 ± 3.5 0.818 
Post-surgical troponin peak (ng/L ± SD) 6993 ± 9227 4676 ± 5117 0.289 
Percentage of fibrosis (% ± SD) 14.5 ± 6.4 19.5 ± 6.8 0.033** 
Adipocites infiltration (n/mm  ± SD) 1.5 ± 5.3 1.4  ± 2.1 0.926 
Table III: Comparison of variables between populations that developed atrial fi-
brillation and those that did not develop arrhythmia. AF: atrial fibrillation, BMI: 
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body mass index, ACS: acute coronary syndrome, EF: ejection fraction, TAPSE: 
tricuspid annular plane systolic excursion, MAPSE: mitral annular plane systolic 
excursion. 
 
The population that developed atrial fibrillation had some important atrial parame-
ters significantly different in comparison to the population that did not develop ar-
rhythmia, in particular a higher atrial volume, a higher degree of diastolic disfunc-
tion expressed by the E/A wave ratio and a higher epicardial fat thickness meas-
ured on the echocardiogram. This population also had a significantly higher aver-
age age. Laboratory analysis showed that patients with atrial fibrillation had a sig-
nificantly higher percentage of fibrosis in the biopsy, while the comparison of adi-
pocyte infiltration between the two populations was not significant (Figure 4). The 
remaining parameters compared were not significantly different between the two 
populations, in particular the male gender, body mass index, arterial hypertension, 
dyslipidemia, total blood cholesterol, statin therapy before admission, chronic re-
nal failure, tobacco smoke, diabetes mellitus, peripheral vasculopathy, acute coro-
nary syndrome at admission, ejection fraction, TAPSE (tricuspid annular pla-ne 
systolic excursion), MAPSE (mitral annular plane systolic excursion), E/E' ratio, 
paracardial and pericardial fat thickness. 
 
 
Figure 4: Significant images of PLIN1(+) adipocytes between the cardiomyocytes 
(bar scales = 25µm) of two patients in the study. A patient who didn’t develop 
postoperative atrial fibrillation. B Patient who developed postoperative atrial 
fibrillation. 
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The variables found to be significantly different in the two populations were sub-
sequently subjected to univariate analysis for the study of the variables associated 
with the onset of atrial fibrillation in the postoperative period. Finally, all varia-
bles tested in the univariate analysis were subjected to MANOVA analysis to test 
the predictive value of these variables independently. Among these atrial size, 
atrial fibrosis and age were found to be independent predictors of postoperative 
atrial fibrillation (Table IV). 
 
Clinical Variables OR 95% CI P value 
Univariate Analysis – Logistic Regression 
Age 1.17 1.07-1.28 0.001 
Atrial Volume 1.05 1.01-1.09 0.022 
E/A rate 0.04 0.02-0.72 0.029 
Epicardial Fat 1.49 1.09-2.04 0.012 
Atrial Fibrosis (percentage) 1.12 1.00-1.25 0.045 
Multivariate Analysis – MANOVA 
Atrial Volume 0.027 
Atrial Fibrosis 0.003 
Age 0.039 
Table IV: Univariate and Multivariate Analysis on variables related to atrial fi-
brillation onset after cardiac surgery.  
 
Primary endpoint  
The analysis of the primary endpoint from the data shows a significant difference 
in epicardial fat between the two populations that either developed or did not de-
velop postoperative atrial fibrillation. Epicardial fat has an Odds Ratio of 1.49 
[1.09-2.04] in predicting the onset of postoperative atrial fibrillation. When tested, 
the predictive value in a ROC analysis, the area under the curve (AUC) has a val-
ue of 0.73 (p=0.004), and a cut-off of 4 mm has a 73% sensitivity and 89% speci-
ficity in predicting the event (Figure 5). The predictive power of the 4 mm cut-off 
was also tested with a square Chi test that confirms its validity as a predictive val-
ue (p<0.001). 
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Figure 5: ROC curve. The area under the curve (AUC) has a value of 0. 73 (p=0. 
004), and a cut-off of 4 mm has a 73% sensitivity and 89% specificity in predict-
ing the atrial fibrillation event. 
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DISCUSSION  
 
In this study, the percentage of patients who developed atrial fibrillation is about 
39%, in line with literature data.5-9 It appears to be a strong predictor of atrial 
fibrillation independently of other factors such as age, which is also confirmed by 
several studies.1,2 
With regard to the analysis of atrial fibrillation burden it is important to underline 
that in this study all patients were monitored continuously with telemetry from the 
day of surgery until the day of discharge with a precise definition of the 
arrhythmic burden. In postoperative atrial fibrillation prophylaxis, although our 
data do not show a statistically significant difference between populations, 36 
(64.28%) patients who underwent surgery were on a beta-blocker therapy prior to 
surgery. 17 of these were in the group of patients who developed atrial fibrillation. 
None of them were using a Sotalol or Cordarone treatment before the surgery. All 
patients also had a temporary epicardial pacemaker with atrial and/or ventricular 
stimulation in case of bradycardization and/or conduction blockages which in 
some studies has shown to be associated with a lower incidence of postoperative 
atrial fibrillation.19 Pharmacological treatment of episodes of atrial fibrillation in 
the postoperative period was carried out according to current guidelines3 with the 
administration of amiodarone ev which proved effective in 20 cases out of 22. In 
one case it was necessary to proceed with electrical cardioversion and in another 
case with the strategy of rate control with the choice of a late programmed 
electrical cardioversion. A systematic review of 58 studies with a total of 8565 
patients showed that interventions to prevent and/or treat postoperative atrial 
fibrillation with beta blockers, sotalol or amiodarone and, to a lesser extent, by 
atrial stimulation have a favourable impact on the outcome of cardiac surgery 
patients (atrial fibrillation, stroke, and length of hospital stay- OR 0.43; CI 95% 
0.37-0.51).19 
Of particular relevance in this project is the study of epicardial fat through cardiac 
surgery. There are numerous studies on epicardial fat in the animal model, while 
in humans there are few, all in the context of cardiac surgery. The reason is the 
difficulty to access epicardial fat without undergoing an invasive procedure. 
Università degli Studi di Verona  
Area Ricerca – U.O. Dottorati di Ricerca Nazionali ed Internazionali 
tel. 045.802.8608 - fax 045.802.8411 - Via Giardino Giusti n. 2 - 37129 Verona  
26 
Hiroko Kogo et al.20 conducted a study on 77 patients undergoing both valvular 
and myocardial revascularization cardiac surgery, after measuring epicardial fat at 
the chest CT scan. While the latter parameter was associated with atrial fibrillation 
burden, histological analyses performed on biopsy samples did not show a 
significant correlation between fibrosis and adipose infiltration and atrial 
fibrillation burden. The Qing Wang group conducted research on the inflammatory 
pattern in epicardial fat and atrial fibrillation in patients undergoing heart surgery. 
In particular, in a group of 89 patients in postoperative sinus rhythm, both 
ischemic and valvular, the expression of activin A in epicardial fat, an atrial 
fibrosis marker, was an independent predictor of postoperative atrial fibrillation.21 
In the other study of 64 patients undergoing surgical myocardial revascularization 
(including 28 patients in atrial fibrillation and 36 in sinus rhythm) the presence of 
YKL40 in epicardial fat, an inflammatory remodelling and fibrosis marker, was 
significantly higher in patients in atrial fibrillation, as well as the percentage of 
fibrosis found in the same specimen.22 
 
In this study emerged relevant data regarding pericardial fat and the onset of 
postoperative atrial fibrillation. This could help understand the pathophysiological 
role of this tissue in promoting the creation of a substrate for arrhythmia.  
The relevant points are:  - Epicardial fat, and not paracardial fat, is significantly associated with the 
onset of arrhythmia and is a predictor of the event.  - Adipose infiltration does not appear to be significantly associated with 
atrial fibrillation.  - Fibrosis is significantly higher in the population that developed atrial 
fibrillation and is an event predictor independent of other factors. - Some parameters that reflect diastolic dysfunction are related to the onset 
of atrial fibrillation, including atrial size and E/A ratio. 
 
Epicardial fat  
In the enrolled patients, the thickness of epicardial fat was significantly higher in 
those who developed atrial fibrillation in the postoperative period. In particular a 
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cut-off of 4 mm epicardial fat had a 73% sensitivity and 89% specificity in 
predicting the event. There was also a difference between epicardial fat and 
paracardial fat in relation to the development of atrial fibrillation, because the 
latter does not seem to be significantly related to the event under analysis. A 
similar figure is reported by several imaging studies. Tze Fa Chao et al.23 a pre-
procedural echocardiogram with measurement of epicardial fat thickness in long 
axis parasternal view was performed in 283 patients undergoing transcatheter 
ablation of atrial fibrillation, similarly to what was evaluated in this study. The 
average thickness in the population was 6.1 ± 0.8 mm with a thickness of 7 ± 0.7 
in patients with persistent forms compared to patients with paroxysmal forms of 
atrial fibrillation with 5.9 ± 0.7. Atrial volume and epicardial fat thickness were 
independent predictors of atrial fibrillation recurrence in the follow-up at 16 ± 9 
months. Alexander R. van Rosendael et al.24 quantified posterior atrial wall 
adipose tissue in 400 patients undergoing chest CT scans, 200 with atrial 
fibrillation and 200 with no history of arrhythmia. The adipose tissue was 
significantly more represented in the atrial fibrillation group than the sinus rhythm 
group (10.6 ± 5.5 versus 4.7 ± 3.5 g, P<;0.001) and each additional gram of fat 
was a predictor of atrial fibrillation with an odds ratio of 1.32. In this paper, 
however, there was no clear distinction between epicardial and paracardial fat, but 
the entire pericardial fat was assessed in a different location from that assessed by 
the current research. In these studies, moreover, there were no histological data on 
direct myocardial infiltration and atrial fibrosis.  
An important consideration with regard to the increased amount of epicardial fat 
in the population developing postoperative atrial fibrillation is the clinical impact 
that could result from the reduction of this tissue. In fact, assuming that a greater 
amount of epicardial fat can promote the manifestation of the arrhythmia by 
contributing to the formation of an arrhythmogenic substrate, measures aimed at 
reducing epicardial fat through weight loss, could reduce the arrhythmogen risk 
(in this case considering overweight as a surrogate for a greater amount of 
epicardial fat). In this regard, several studies in the literature show a correlation 
between obesity and increased burden of atrial fibrillation in different populations, 
and conversely, a reduction in atrial fibrillation in patients who experience weight 
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loss in situations of overweight.25 However, in our study the body max index is 
not significantly different in the population with postoperative atrial fibrillation 
compared to the population without postoperative arrhythmia.  
 
Fat infiltration 
The strong association found in this study between epicardial fat, but not with 
paracardial fat, and atrial fibrillation tends to confirm what was previously only 
hypothesised or observed in animal models. The findings suggest the 
pathophysiological role of epicardial fat in promoting the creation of an atrial 
arrhythmic substrate. Indeed, the different histological and functional nature of the 
two different types of epicardial and paracardial fat, and the close relationship of 
physical contiguity without anatomical barriers between epicardium and 
epicardial fat, allows the direct infiltration of the latter which can cause an 
alteration of atrial electrical properties.  
In Friedman DJ et al.26 a study was conducted on pericardial fat and the 
relationship with atrial conduction alterations on a surface ECG. An increased 
representation of pericardial fat as an independent predictor of P-wave index 
alterations in favour of altered atrial conduction was found. In addition, as 
previously demonstrated in the ovine animal model, epicardial fat could directly 
infiltrate the atrial myocardium causing microstructural alterations that are the 
basis of anatomical and electrical atrial remodelling that create the substrate for 
the development of re-entry arrhythmias.18 From our research’s available data, the 
difference in adipose infiltration of the atrial wall in the arrhythmic population 
compared to the non-arrhythmic population is not statistically significant, most 
likely due to insufficient sample numbers. An increase in the sample size may lead 
to different results revealing a higher adipose infiltration of the atrial wall. 
There is little research in the literature on adipose infiltration of the atrial wall also 
because the imaging methods currently available do not allow to quantify the fat 
infiltrated in the thickness of the atrial wall due to its very thin structure. In this 
context more reliable data could be provided by a biopsy, which however cannot 
be performed in vivo outside of the group of patients who already have an 
indication for cardiac surgery. For further knowledge about the degree of fat 
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infiltration in patients developing atrial fibrillation, it is necessary to conduct 
further studies with a larger sample size, although the organisational complexity 
and costs of similar studies may make them difficult to implement. 
 
The role of inflammation  
Epicardial fat, in direct contact with the cardiac surface, has cardioprotective 
properties through biochemical, mechanical and thermoregulation functions and is 
a source of free fatty acids. These activities are also favoured by a dense network 
of vasa-vasorum. However, under pathological conditions this tissue may undergo 
changes in secretory properties with a pattern of pro-inflammatory cytokines, 
promoting a proatherogenic pathological condition and contributing to insulin 
resistance of the myocardium by secretion of TNF-alpha. This inhibits the insulin 
receptor and increases the release of non-esterified fatty acids. What regulates this 
balance is still unclear. Myocardial infiltration by fat in closer contact with the 
myocardium could trigger the cascade of inflammation and initiate the fibrotising 
process of the intercellular spaces, which is also the basis of the histological 
substrate changes observed in re-entry arrhythmias like atrial fibrillation. 
  
Atrial fibrosis  
The histological analysis of this study showed a statistically significant higher 
percentage of fibrosis in the group of patients who developed atrial fibrillation. 
This factor is also an arrhythmic event predictor independently from the other 
variables. The infiltration of epicardial fat under pathological conditions could be 
at the origin of the pathogenetic process that leads to intra myocardial fibrosis of 
the interstitial spaces and the arrhythmogenic substrate that is created. The 
epicardial fat in fact, and in particular its infiltration, could play a central 
pathogenetic role contributing to myocardial fibrosis of the adjacent myocardium. 
This may occur through paracrine activity with the secretion of profibrotic factors, 
such as pro-inflammatory cytokines, growth factors and metal proteases. In 
Werner S et al.27 when the secretoma of interventricular and atrioventricular 
epicardial fat, obtained during surgery of sinus rhythm patients, was applied in 
vitro on the murine atrium, it induced massive myocardial fibrosis in a few days. 
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If the secretoma of the subcutaneous adipose tissue of the same patient was used 
in the same way, it had no effect on the atrial myocardium. These different results 
reflect the different nature of the two tissues, indicating the profibrotic effect as 
specific to epicardial fat, with the ability to transform fibroblasts into 
myofibroblasts. Intramyocardial fibrosis plays a central role in the de-structuring 
of the original atrial histological architecture through the creation of anatomical 
and functional barriers that lead to the formation of uni/bidirectional block points 
and lines of the electrical signal conduction. The substrate thus modified is also 
characterised by a shortening of the refractory periods, which facilitates the 
shortening of the wavelength and the reduction of the excitable gap. These 
modifications are at the basis of the onset of the perpetuation of complex re-entry 
arrhythmias such as atrial fibrillation. In the ovine model of comparison between 
obese and normal weight sheep, the electro-anatomical endocavitary study of the 
left atrium with Carto system (Biosense Webster) showed minor voltages in the 
posterior atrial wall with a greater heterogeneity of voltages in the group of obese 
sheep. In addition, this group of sheep, in the analysis of the histological 
preparation, had a significantly higher percentage of fibrosis than normal weight 
sheep.18 
 
Diastolic dysfunction  
In regard to the atrial parameters measured using echo method, the atrial 
dimension is significantly greater in patients who develop atrial fibrillation. It is 
also a predictor of arrhythmia independent of the other factors with an odds ratio 
of 1.05. Numerous studies confirm the importance of the atrial size as a predictor 
of atrial fibrillation. In a study with 3467 enlisted CT patients who underwent 
atrial size and pericardial fat measurement, atrial size was a strong independent 
predictor of atrial fibrillation [2.70 (2.22 - 2.20), P 0.0001], while epicardial fat 
was not.28 Atrial size is usually the cause and/or consequence of atrial remodelling, 
which in turn involves electrical remodelling favouring the substrate for atrial 
fibrillation. In addition to this, other known predictors of atrial dysfunction such 
as E/A ratio were found to be related to the onset of postoperative atrial 
fibrillation. These elements are generally early indicators of underlying atrial 
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dysfunction and/or remodelling. In this context the atrial dimensions and the E/A 
ratio can be considered as a marker of a functional arrangement of an initial 
modification of the substrate in an arrhythmogenic sense, even before the 
arrhythmia has occurred.  
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CONCLUSION  
 
Postoperative atrial fibrillation in patients undergoing aortic coronary artery 
bypass surgery is related to an increased presence of epicardial fat. From a 
histological analysis of the atrium in patients who develop postoperative atrial 
fibrillation there is an increased amount of fibrosis. From a pathophysiological 
point of view epicardial fat may play a fundamental role in the development of 
atrial fibrillation in two ways: direct infiltration causing an alteration of atrial 
structural and electrical properties and indirectly through paracrine activity of 
inflammation modulators and oxidative stress on the myocardium, which in turn 
promotes fibrosis. In this scenario the microscopic/histological alterations 
observed could be considered early markers of substrate evolution in an 
arrhythmic sense and confirm the pathogenetic importance for the development of 
atrial fibrillation. Lastly, age, atrial size and amount of atrial fibrosis are 
independent predictors of postoperative atrial fibrillation development. 
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